- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02010138
Extent of ILM Removal and Its Impact on Outcomes of MH Surgery
Extent of Internal Limiting Membrane Removal and Its Impact on Outcomes of Macular Hole Surgery
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This randomized clinical trial was performed at a single center. Patients who were scheduled for surgery for idiopathic macular hole (MH) were enrolled. Eligible patients were equally randomized to small extent group or large extent group depending on the extent of ILM to be removed. Random numbers were generated through computerized block-randomization.
A standard 3-port pars plana vitrectomy was performed by a single surgeon using 23-gauge vitrectomy system, with a 1-step scleral tunnel incision. After posterior vitreous detachment was achieved, peeling of the ILM was performed by an end gripping forceps with the assistance of indocyanine green dye. The ILM was peeled in round shape with the radius of either 0.75-disc diameter or 1.5-disc diameter centering at the center of the MH according to the pre-assigned group. This was followed by a complete fluid-gas exchange, and all patients were encouraged to maintain a face-down position for at least 5 days postoperatively.
Postoperative measurements of BCVA and M-score were conducted at 2- and 6-month follow-up visits by independent masked observers. The first postoperative SD-OCT scanning was usually conducted at 1 to 2 weeks after operation according to the intraocular gas status. Then, OCT scans were conducted at follow-up visits 2, and 6 months postoperatively. The same experienced examiner conducted all the OCT scans on all subjects.
Comparison of anatomical closure, BCVA, M-score, Δ BCVA, and Δ M-score were primarily performed between the two groups. Then, the parameters measured from OCT scans with changes in ETDRS visual acuity and M-score were analyzed.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Seoul, Korea, Republikken, 06315
- Samsung Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- idiopathic macular hole
Exclusion Criteria:
- macular hole associated with other causative diseases
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Small Extent Group (SG)
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the SG.
The small-extent peeling was performed in SG.
|
The internal limiting membrane was peeled in round shape with the radius of 0.75-disc diameter radius (1.5-disc diameter in total) centering at the center of the macular hole.
|
|
Aktiv komparator: Large Extent Group (LG)
Patients who were scheduled for surgery for idiopathic macular hole were randomly assigned to the LG.
The large-extent peeling was performed in LG.
|
The internal limiting membrane was peeled in round shape with the radius of 1.5-disc diameter radius (3.0-disc diameter in total) centering at the center of the macular hole.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Degree of foveal elongation
Tidsramme: postoperative 6months
|
postoperative 6months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
metamorphopsia
Tidsramme: 6months
|
6months
|
Andre resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
ændring i synsstyrken
Tidsramme: 6 måneder
|
6 måneder
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Kunho Bae, MD, Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2013-07-083
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Macula huller
-
The Lowy Medical Research Institute LimitedUkendtMacula Pigment | Macular TeleangiectasiaTyskland
-
The Lowy Medical Research Institute LimitedIkke rekrutterer endnuMacular Telangiectasia Type 2 (MacTel)Australien, Forenede Stater, Det Forenede Kongerige, Tyskland, Holland
-
Carl Zeiss Meditec, Inc.DataMed Devices Inc.AfsluttetTør AMD Med Macular DrusenForenede Stater
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedAfsluttetMacular Telangiectasia Type 2Forenede Stater, Tyskland, Australien
-
The Lowy Medical Research Institute LimitedAktiv, ikke rekrutterendeMacular Telangiectasia Type 2Forenede Stater, Det Forenede Kongerige
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedAfsluttetMacular Telangiectasia Type 2 (MacTel)Det Forenede Kongerige, Forenede Stater, Frankrig, Australien
-
Neurotech PharmaceuticalsThe Lowy Medical Research Institute LimitedAfsluttetMacular Telangiectasia Type 2Forenede Stater, Australien
-
Neurotech PharmaceuticalsThe Emmes Company, LLC; The Lowy Medical Research Institute LimitedAfsluttetMacular Telangiectasia Type 2Forenede Stater, Australien
-
Neurotech PharmaceuticalsAktiv, ikke rekrutterendeMacular Telangiectasia Type 2Forenede Stater
-
Neurotech PharmaceuticalsRekrutteringMacular Telangiectasia Type 2 (MacTel)Forenede Stater, Australien
Kliniske forsøg med small-extent peeling
-
Rush Eye AssociatesAktiv, ikke rekrutterendeDiabetisk retinopati visuelt truendeMexico
-
Federal University of São PauloUkendtMacula hullerBrasilien
-
Czech Technical University in PragueUniversity Hospital, MotolRekrutteringNeonatal åndedrætsbesvær | Spædbarn med meget lav fødselsvægtTjekkiet
-
University Medical Center Ho Chi Minh City (UMC)Ikke rekrutterer endnu
-
Nantes University HospitalAfsluttet
-
Fondazione Policlinico Universitario Agostino Gemelli...AfsluttetImplantatkomplikationItalien
-
Peking University People's HospitalPeking Union Medical College Hospital; Beijing Tongren Hospital; Beijing...UkendtKirurgi | Idiopatisk makulært hulKina
-
Peking University People's HospitalAfsluttet
-
Wenzhou Medical UniversityUkendt